Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,759,304
+$392,368 QoQ
Shares Held
293,707
+25.3% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. ARDX ranks #143 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in ARDX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,759,304 | 293,707 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,366,936 | 234,466 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,252,533 | 227,320 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $812,423 | 207,251 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $897,518 | 182,794 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $825,517 | 162,824 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,403,221 | 1,074,488 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,738,315 | 1,719,071 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $28,571,199 | 3,913,863 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,441,448 | 2,329,266 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $7,067,240 | 1,732,167 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,012,374 | 1,773,562 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,271,002 | 2,561,796 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,544,814 | 2,296,426 | Shares | Sole | 2023-02-14 | |
| 2021-06-30 | $18,079,527 | 2,385,162 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,346,388 | 2,469,243 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,174,450 | 2,499,915 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,451,786 | 2,562,245 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $19,322,709 | 2,792,299 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $16,745,019 | 2,945,474 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||